No black box warning on record for Duobrii
As of the latest FDA labeling reviewed, Duobrii (HALOBETASOL PROPIONATE AND TAZAROTENE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Duobrii medicine page for the complete safety profile.